Close

Medtronic, Inc. (MDT) PT Lowered to $85 at Leerink Partners; Hurricane Maria a Significant Headwind

Go back to Medtronic, Inc. (MDT) PT Lowered to $85 at Leerink Partners; Hurricane Maria a Significant Headwind

Medtronic, Inc. (MDT) PT Lowered to $89 at BMO Capital; 'Updating Model for Hurricane Maria... $250M Impact to Manufacturing in PR'

October 10, 2017 10:07 AM EDT

BMO Capital lowered its price target on Medtronic, Inc. (NYSE: MDT) to $89.00 (from $92.00) while maintaining a Outperform rating, following a model update due to impact of Hurricane Maria.

Analyst Joanne Wuensch notes a cautious outlook following a model update with management citing a $250... More

Medtronic, Inc. (MDT) PT Lowered to $94 at Needham & Company; 'Lowering Estimates for Hurricane Maria Manufacturing Impact'

October 10, 2017 7:59 AM EDT

Needham & Company lowered its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $95.00) while maintaining a Buy rating, following an update on the impact of Hurricane Maria.

Analyst Mike Matson notes a cautious outlook, as the company reported damage caused by Hurricane Maria... More

Medtronic (MDT) Granted FDA Approval for Endurant II/IIs Stent Graft System

October 9, 2017 8:07 AM EDT

Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the Endurant(TM) II/IIs stent graft system to treat abdominal aortic aneurysm (AAA) patients with neck lengths down to 4mm and... More

Medtronic, Inc. (MDT) PT Lowered to $83 at Stifel on Hurricane Maria Update; 'Four Major Manufacturing Facilities Sustained Some Damage'

October 9, 2017 7:47 AM EDT

Stifel lowered its price target on Medtronic, Inc. (NYSE: MDT) to $83.00 (from $91.00) while maintaining a Hold rating, following the company's update on Hurricane Maria in Puerto Rico.

Analyst Rick Wise notes a cautious outlook following the company's update on Hurricane Maria in Puerto... More

Wells Fargo Downgrades Medtronic, Inc. (MDT) to Market Perform, Guidance Looks Aggressive

October 9, 2017 2:48 AM EDT

Wells Fargo downgraded Medtronic, Inc. (NYSE: MDT) from Outperform to Market Perform with a price target of $83.00 (from $93.00).

Analyst Larry Biegelsen says the product cycle is hitting a lull and sees headwinds from a plethora of competitive challenges in cardiac/vascular... More